Sandrine Hayette

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP)

Franck E. Nicolini, Sélim Corm, Q.H. Le et al. · Leukemia · 2006 · 203 citations

Hematological Malignancy, Medicine, Hematology +9

EZH2 alterations in follicular lymphoma: biological and clinical correlations

Sarah Huet, Luc Xerri, Bruno Tesson et al. · Blood Cancer Journal · 2017 · 94 citations · Full text

Histone Modifications, Epigenetic Change, Genetics +19

The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis

Franck E. Nicolini, A. R. Ibrahim, Simona Soverini et al. · Haematologica · 2013 · 78 citations · Full text

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

Gabriel Étienne, Stéphanie Dulucq, Franck E. Nicolini et al. · Haematologica · 2013 · 60 citations · Full text

Engineering, Imatinib Front-line Therapy, Better Clinical Outcome +19

Autolysosomes accumulate during in vitro CD8+ T-lymphocyte aging and may participate in induced death sensitization of senescent cells

Luc‐Marie Gerland, Laurent Genestier, S Peyrol et al. · Experimental Gerontology · 2004 · 59 citations

Inflammation, Induced Death Sensitization, Autoimmune Disease +11